受强制性开放获取政策约束的文章 - Pramod Mistry了解详情
无法在其他位置公开访问的文章：2 篇
Recombinant macrophage targeted enzyme replacement therapy for Gaucher disease in India
A Nagral, P Mewawalla, S Jagadeesh, M Kabra, SR Phadke, IC Verma, ...
Indian pediatrics 48, 779-784, 2011
强制性开放获取政策： US National Institutes of Health
Reply to:“Whole exome sequencing for personalized hepatology: Expanding applications in adults and challenges”
A Hakim, PK Mistry, S Vilarinho
Journal of Hepatology 71 (4), 850-851, 2019
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：79 篇
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
PK Mistry, J Liu, M Yang, T Nottoli, J McGrath, D Jain, K Zhang, J Keutzer, ...
Proceedings of the National Academy of Sciences 107 (45), 19473-19478, 2010
强制性开放获取政策： US National Institutes of Health
The risk of Parkinson’s disease in type 1 Gaucher disease
G Bultron, K Kacena, D Pearson, M Boxer, R Yang, S Sathe, G Pastores, ...
Journal of inherited metabolic disease 33, 167-173, 2010
强制性开放获取政策： US National Institutes of Health
Consensus Conference: A reappraisal of Gaucher disease-diagnosis and disease management algorithms
PK Mistry, MD Cappellini, E Lukina, H Özsan, SM Pascual, H Rosenbaum, ...
American journal of hematology 86 (1), 110, 2011
强制性开放获取政策： US National Institutes of Health
Glucosylsphingosine promotes α-synuclein pathology in mutant GBA-associated Parkinson's disease
YV Taguchi, J Liu, J Ruan, J Pacheco, X Zhang, J Abbasi, J Keutzer, ...
Journal of Neuroscience 37 (40), 9617-9631, 2017
强制性开放获取政策： US National Institutes of Health
Clonal immunoglobulin against lysolipids in the origin of myeloma
S Nair, AR Branagan, J Liu, CS Boddupalli, PK Mistry, MV Dhodapkar
New England Journal of Medicine 374 (6), 555-561, 2016
强制性开放获取政策： US National Institutes of Health
Glucosylsphingosine is a key biomarker of Gaucher disease
V Murugesan, WL Chuang, J Liu, A Lischuk, K Kacena, H Lin, ...
American journal of hematology 91 (11), 1082-1089, 2016
强制性开放获取政策： US National Institutes of Health
The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients
TH Taddei, KA Kacena, M Yang, R Yang, A Malhotra, M Boxer, KA Aleck, ...
American journal of hematology 84 (4), 208-214, 2009
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history
HN Baris, IJ Cohen, PK Mistry
Pediatric endocrinology reviews: PER 12 (0 1), 72, 2014
强制性开放获取政策： US National Institutes of Health
Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial
PK Mistry, E Lukina, HB Turkia, D Amato, H Baris, M Dasouki, M Ghosn, ...
Jama 313 (7), 695-706, 2015
强制性开放获取政策： US National Institutes of Health
Gaucher disease: Progress and ongoing challenges
PK Mistry, G Lopez, R Schiffmann, NW Barton, NJ Weinreb, E Sidransky
Molecular genetics and metabolism 120 (1-2), 8-21, 2017
强制性开放获取政策： US National Institutes of Health
Gaucher disease in bone: from pathophysiology to practice
D Hughes, P Mikosch, N Belmatoug, F Carubbi, TM Cox, O Goker‐Alpan, ...
Journal of Bone and Mineral Research 34 (6), 996-1013, 2019
强制性开放获取政策： US National Institutes of Health, Swedish Research Council for Environment …
Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation
S Nair, CS Boddupalli, R Verma, J Liu, R Yang, GM Pastores, PK Mistry, ...
Blood, The Journal of the American Society of Hematology 125 (8), 1256-1271, 2015
强制性开放获取政策： US National Institutes of Health
Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease
PK Mistry, J Liu, L Sun, WL Chuang, T Yuen, R Yang, P Lu, K Zhang, J Li, ...
Proceedings of the National Academy of Sciences 111 (13), 4934-4939, 2014
强制性开放获取政策： US National Institutes of Health
Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity
MB Hammer, G Eleuch-Fayache, LV Schottlaender, H Nehdi, JR Gibbs, ...
The American Journal of Human Genetics 92 (2), 245-251, 2013
强制性开放获取政策： US National Institutes of Health
Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults
PK Mistry, NJ Weinreb, P Kaplan, JA Cole, AR Gwosdow, T Hangartner
Blood Cells, Molecules, and Diseases 46 (1), 66-72, 2011
强制性开放获取政策： US National Institutes of Health
Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis
PK Mistry, P Deegan, A Vellodi, JA Cole, M Yeh, NJ Weinreb
British journal of haematology 147 (4), 561-570, 2009
强制性开放获取政策： US National Institutes of Health
Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism
PK Mistry, T Taddei, S vom Dahl, BE Rosenbloom
Critical Reviews™ in Oncogenesis 18 (3), 2013
强制性开放获取政策： US National Institutes of Health
Life expectancy in Gaucher disease type 1
NJ Weinreb, P Deegan, KA Kacena, P Mistry, GM Pastores, P Velentgas, ...
American journal of hematology 83 (12), 896-900, 2008
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定